AMRN
Amarin
Stock NASDAQ – Stock Market Prices, News & Analysis
Amarin Corporation est une entreprise pharmaceutique spécialisée dans la recherche, le développement et la commercialisation de traitements pour les maladies cardiovasculaires.
Amarin
AMRN
Amarin Corporation est une entreprise pharmaceutique spécialisée dans la recherche, le développement et la commercialisation de traitements pour les maladies cardiovasculaires.
Price history of Amarin
Price history of Amarin
Performance & Momentum
Amarin Posts Strong 2025 Results, Promising 2026 Outlook
Amarin Corporation (NASDAQ: AMRN) reported preliminary 2025 financial results exceeding expectations, including positive cash flow starting in Q4 and planned operational savings of $70 million by mid-2026. The company has strengthened its position in the cardiovascular market through its VASCEPA®/VAZKEPA® franchise, benefiting from therapeutic advances for patients with high triglycerides. These achievements and its international partnership-driven strategy underpin solid global growth prospects for 2026.
Similar stocks to Amarin
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
